Provenzano, E., Vallier, A. -L., Champ, R., Walland, K., Bowden, S. (Sarah), Grier, Anna, Fenwick, Nicola, Abraham, J. (Janet), Iddawela, M., Caldas, C., Hiller, Louise, Dunn, Janet A. and Earl, Helena M.. (2013) A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer, Volume 108 (Number 4). pp. 866-872. ISSN 0007-0920

Taggart, Frances M., Donnelly, Peter K. and Dunn, Janet A.. (2012) Options for early breast cancer follow-up in primary and secondary care : a systematic review. BMC Cancer, Vol.12 (No.1). p. 238. ISSN 1471-2407

. (2012) Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer : results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials. British Journal of Cancer, Vol.107 (No.8). pp. 1257-1267. ISSN 0007-0920

Bradley, A., Marshall, A., Abdelaziz, M., Hussain, K., Agostini, P., Bishay, E., Kalkat, M., Steyn, R., Rajesh, P., Dunn, Janet A. and Naidu, Babu V.. (2012) Thoracoscore fails to predict complications following elective lung resection. European Respiratory Journal, Vol.40 (No.6). pp. 1496-1501. ISSN 0903-1936

Iqbal, Gulnaz, Johnson, Mark, 1948 Mar. 16-, Szczepura, Ala, Wilson, Sue, Gumber, Anil and Dunn, Janet A.. (2012) UK ethnicity data collection for healthcare statistics : the South Asian perspective. BMC Public Health, Vol.12 (No.1). p. 243. ISSN 1471-2458

Spooner, D., Stocken, D. D., Jordan, S., Bathers, S., Dunn, Janet A., Jevons, C., Dodson, L., Morrison, J. M., Oates, G. D. and Grieve, R. J.. (2012) A randomised controlled trial to evaluate both the role and the optimal fractionation of radiotherapy in the conservative management of early breast cancer. Clinical Oncology, Vol.24 (No.10). pp. 697-706. ISSN 0936-6555

Tudur Smith, Catrin, Stocken, Deborah D., Dunn, Janet A., Cox, Trevor F., Ghaneh, Paula, Cunningham, David, 1954 Dec. 4- and Neoptolemos, John P.. (2012) The value of source data verification in a cancer clinical trial. PLoS ONE , Vol.7 (No.12). e51623. ISSN 1932-6203

Hiller, Louise, Dunn, Janet A., Higgins, Helen B., Ogburn-Storey, Emma, Loi, Shrushma, Vallier, Anne-Laure and Earl, Helena M.. (2011) Optimising patient recall of adverse events over prolonged time periods. Trials, Vol.12 (Suppl.1). A74. ISSN 1745-6215

Marshall, A. (Andrea), Dunn, Janet A., Fletcher, Julie, Higgins, Helen B. and Poole, Christopher (2011) The importance of planning for a seamless transition in an adaptive phase II randomised trial. Trials, Vol.12 (Suppl.1). A7. ISSN 1745-6215

Campbell, H. E., Epstein, D., Bloomfield, D., Griffin, S., Manca, A., Yarnold, J., Bliss, J., Johnson, L., Earl, H., Poole, Christopher, Hiller, Louise, Dunn, Janet A., Hopwood, P., Barrett-Lee, P., Ellis, P., Cameron, D., Harris, A. L., Gray, A. M. and Sculpher, Mark J.. (2011) The cost-effectiveness of adjuvant chemotherapy for early breast cancer : a comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. European Journal of Cancer, Vol.47 (No.17). pp. 2517-2530. ISSN 0959-8049

Ishak, K. Jack, Caro, J. Jaime, Drayson, Mark T., Dimopoulos, Meletios, Weber, Donna, Augustson, Bradley, Child, J. Anthony, Knight, Robert, Iqbal, Gulnaz, Dunn, Janet A., Shearer, Arran and Morgan, Gareth. (2011) Adjusting for patient crossover in clinical trials using external data : a case study of lenalidomide for advanced multiple myeloma. Value in Health, Vol.14 (No.5). pp. 672-678. ISSN 1098-3015

Midgley, Rachel S., McConkey, Christopher C., Johnstone, Elaine C., Dunn, Janet A., Smith, Justine L., Grumett, Simon A., Julier, Patrick, Iveson, Claire, Yanagisawa, Yoko, Warren, Bryan, Langman, Michael J. and Kerr, David J.. (2010) Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. Journal of Clinical Oncology, Vol.28 (No.30). pp. 4575-4580. ISSN 0732-183X

Bartlett, John M. S., Munro, Alison F., Dunn, Janet A., McConkey, Christopher C., Jordan, S., Twelves, Chris, Cameron, D. (David), 1956-, Thomas, Jeremy St. J., Campbell, Fiona M., Rea, Daniel W., Provenzano, Elena, Caldas, Carlos, Pharaoh, Paul, Hiller, Louise, Earl, Helena M. and Poole, Christopher. (2010) Predictive markers of anthracycline benefit : a prospectively planned analysis of the UK national epirubicin adjuvant trial (NEAT/BR9601). Lancet Oncology, Vol.11 (No.3). pp. 266-274. ISSN 1470-2045

Bartlett, J. M. S., Munro, A., Desmedt, C., Dunn, Janet A., Larsimont, D., O'Malley, F. P., Cameron, D. A., Earl, H., Poole, Christopher, Shepherd, L., Cardoso, F., Caldas, C., Twelves, C. J., Pritchard, K., Rea, D. W. and diLeo, A. (2009) Duplication of chromosome 17 CEP predicts for anthracycline benefit: a meta-analysis of 4 trials. In: 32nd Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 09-13, 2009. Published in: Cancer Research, Vol.69 (No.24 Suppl. 3). 716S-716S.

Iqbal, Gulnaz, Gumber, Anil, Johnson, Mark, 1948 Mar. 16-, Szczepura, Ala, Wilson, Sue and Dunn, Janet A.. (2009) Improving ethnicity data collection for health statistics in the UK. Diversity in Health and Care, Vol.6 (No.4). pp. 267-285. ISSN 1759-1422

. (2009) Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. Journal of Clinical Oncology, Vol.27 (No.33). pp. 5513-5518. ISSN 0732-183X

Bartlett, J. M. S., Munro, A., Dunn, Janet A., Hiller, Louise, Jordan, S., Twelves, C. J., Cameron, D. A., Thomas, J., Campbell, F., Rea, D. W., Provenzano, E., Pharoah, P., Caldas, C., Earl, H. and Poole, Christopher (2009) Chromosome 17 polysomy (Ch17) as a predictor of anthracycline response: emerging evidence from the UK NEA Tadjuvant breast cancer trial. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 74S-74S.

Spooner, D., Stocken, D. D., Jordan, S., Bathers, S., Dunn, Janet A., Jevons, C., Morrison, M., Oates, G. and Grieve, R. (2009) A randomised controlled trial to evaluate both the role and optimal fractionation of radiotherapy in the conservative management of early breast cancer. In: 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008. Published in: Cancer Research, Vol.69 (No.2 Suppl. S). 338S-338S.

Wong, Wai Lup, Nutting, Chris, Dunn, Janet A., Fisher, Sheila, MacLennan, Ken, MacCabe, Chris and Mehanna, Hisham M. (2009) Advanced head and neck cancer: is there a role for fluorodeoxyglucose PET/computed tomography? Nuclear Medicine Communication, Vol.30 (No.1). pp. 2-4. ISSN 0143-3636

Biswas, S., Wrigley, J., East, C., Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, P., Middleton, M. (Mark) and Corrie, P.. (2008) A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma : an update. ecancermedicalscience, Vol.2 . p. 108. ISSN 1754-6605

Behalf NEAT Investigators (Including: Earl, H. M., Hiller, Louise, Dunn, Janet A., Bathers, S., Harvey, P., Stanley, A., Grieve, R. J., Agrawal, R. K., Fernando, I. N., Brunt, A. M., McAdam, K., O'Reilly, S., Rea, D. W., Spooner, D. and Poole, Christopher). (2008) NEAT : national epirubicin adjuvant trial - toxicity, delivered dose intensity and quality of life. British Journal of Cancer, Vol.99 (No.8). pp. 1226-1231. ISSN 0007-0920

Biswas, S., East, C., A'Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, Paul, Middleton, M. (Mark) and Corrie, P. (2008) Adjuvant bevacizumab is safe treatment for melanoma patients at high risk of recurrence. In: 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008. Published in: Annals of Oncology, Vol.19 (Suppl.8). pp. 245-246.

Midgley, Rachel S. J., McConkey, Christopher C., Langman, Michael J., Smith, Justine L., Julier, Patrick, Iveson, Claire, Johnstone, Elaine, Chen, Xiao-he, Dunn, Janet A. and Kerr, David J. (2008) VICTOR : a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection. In: 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008. Published in: Annals of Oncology, Vol.19 (No.19 ). p. 1.

tAnGo Trial Collaborators (Including: Wardley, A. M., Hiller, Louise, Howard, H. C., Dunn, Janet A., Bowman, A., Coleman, R. E., Fernando, I. N., Ritchie, D. M., Earl, H. M. and Poole, Christopher). (2008) tAnGo : a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer : a prospective pulmonary, cardiac and hepatic function evaluation. British Journal of Cancer, Vol.99 (No.4). pp. 597-603. ISSN 0007-0920

Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, J. L., Midgley, Rachel S. J., Iveson, Claire and McConkey, Christopher C. (2008) VICTOR : a phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection. Journal of Clinical Oncology, Vol.26 (No.15S). p. 4038. ISSN 0732-183X

Ishak, K., Deniz, B., Drayson, Mark T., Morgan, G. J., Augustson, B., Child, A., Begum, Gulnaz, Dunn, Janet A., Shearer, Arran and Caro, J. Jaime (2008) Modeling overall survival in the event of patient cross-over from dexamethasone to lenalidomide in phase III multiple myeloma trials. In: 48th Annual Scientific Meeting of the British-Society-for-Haematology, Glasgow, Scotland, Apr 07-09, 2008. Published in: British Journal of Haematology, Volume 141 (Supplement 1). p. 121.

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Need for the iBreast trial – risk adjusted breast cancer follow-up trial. BMJ . ISSN 0959-535X

Donnelly, Peter K., Hiller, Louise and Dunn, Janet A. (2008) Follow-up after breast cancer : national randomised controlled trial is needed. British Medical Journal, Vol.336 (No.7642). pp. 461-462. ISSN 0959-8146

Friede, Tim, Dunn, Janet A. and Stallard, Nigel (2008) Clinical trials in oncology. In: Missailidis, Sotiris, (ed.) Anticancer therapeutics. Oxford ; Hoboken, NJ: Wiley-Blackwell, pp. 365-375. ISBN 9780470723036

Hiller, Louise, Fenwick, N., Vallier, A. L., Dunn, Janet A., Hilborne, S., Jones, L., Abraham, J., Iddawela, M., Caldas, C. and Earl, H. M. (2007) The challenges of using radiological 'tumour response' as an endpoint in Neo-tAnGo: a national neo-adjuvant chemotherapy breast cancer trial. In: 10th Nottingham International Breast Cancer Conference, Nottingham, England, September 18-20, 2007. Published in: European Journal of Cancer Supplements, Vol.5 (No.3). pp. 33-34.

Vioxx in Colorectal Cancer Therapy: Definition of Optimal Regime (VICTOR) Trial Group (Including: Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, Justine L., Midgley, Rachel S. J., Stanley, Andrew, Stokes, Joanne C., Julier, Patrick, Iveson, Claire, Duvvuri, Ravi and McConkey, Christopher C.). (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. New England Journal Of Medicine , Vol.357 (No.4). pp. 360-369. ISSN 0028-4793

VICTOR Trial Grp (Including: Kerr, David J., Dunn, Janet A., Langman, Michael J., Smith, Justine L., Midgley, Rachel S. J., Stanley, Andrew, Stokes, Joanne C., Julier, Patrick, Iveson, Claire, Duvvuri, Ravi and McConkey, Christopher C.). (2007) Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer. New England Journal Of Medicine , Vol.357 (No.4). pp. 360-369. ISSN 0028-4793

Drayson, M. T., Augustson, B. M., Begum, G., Dunn, Janet A., Barth, N. J., Davies, F., Morgan, G., Behrens, J., Smith, A. and Child, J. A. (2007) Survival from relapse and the influence of therapy. In: 11th International Myeloma Workshop/4th International Workshop on Wladenestroms Macroglobulinemia, Kos Isl, Greece, June 25-30, 2007. Published in: Haematologica, Vol.92 (No.6 Suppl. 2). p. 173.

Wilson, Sue, Dr, Wakelam, Michael J.O., Hobbs, Richard F. D., Ryan, Angela V., Dunn, Janet A., Redman, Val. D., Patrick, Fiona, Colbourne, Lynne and Martin, Ashley. (2006) Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population. BMC Cancer, Vol.6 (No.25). ISSN 1471-2407

Ryan, Angela V., Wilson, Sue, Dr, Wakelam, Michael J. O., Warmington, Sally A., Dunn, Janet A., Hodgkin, Richard F. D., Martin, Ashley and Ismail, Tariq. (2006) A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer. BMC Cancer, Vol.6 (No.251). ISSN 1471-2407

Poole, C. J., Hiller, Louise, Howard, H. C., Loi, S., Dunn, Janet A., Canney, P., Wardley, A. M., Crown, J. P., Coleman, R. E., Verrill, M. W., Ellis, P. A., Leonard, R. C., Spooner, D. and Earl, H. M. (2006) Tolerability of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy in the randomized phase III tAnGo trial for invasive higher risk early stage breast cancer. In: 29th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, DEC 14-17, 2006. Published in: BREAST CANCER RESEARCH AND TREATMENT, 100 (Suppl. 1). S114-S114.